Back to
Capitolis Liquid Global Markets LLC
RIGL
4 quarters
Position history for
Capitolis Liquid Global Markets LLC's holdings in Rigel Pharmaceuticals, Inc.
No. Capitolis Liquid Global Markets exited its RIGL (Rigel Pharmaceuticals) position in Q4 2025. Its Q3 2025 13F listed 591,553 shares worth $16.8M. Capitolis Liquid Global Markets first reported RIGL in Q1 2025 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$12.5M
Total Shares Change
-693,100
Quarter-by-Quarter History